Biotek-snakken — November 2019
-
BGBIO præsentation fra SITC https://twitter.com/notthatjensmith/status/1193040430407004160
-
Ultimovacs ASA – LONG TERM RESULTS FROM UV1 CLINICAL STUDY IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
Oslo,9 November 2019: Ultimovacs ASA (“Ultimovacs”, ticker ULTIMO), a pharmaceutical company developing novel immunotherapies against cancer, presents long-term results from a clinical study with UV1 in patients with Non-Small Cell Lung Cancer (“NSCLC”) during a poster session at the Society for Immunotherapy of Cancer’s 34th Annual Meeting (SITC 2019) today.https://newsweb.oslobors.no/message -
NextCure, der steg et par hundrede % i tirsdags, præsenterer også på SITC senere i dag http://ir.nextcure.com/events/event-details/nextcure-investor-day
-
Cantargia - analyse fra Redeye. https://www.proinvestor.com/?p=debat_1&postid=78487&thread=50&start=50#79027
-
God morgen.
-
Nextcure står vist til en ørefigen i morgen https://twitter.com/andybiotech/status/1193566914187915264?s=21
-
-
Alligator prækliniske data: http://www.firstwordpharma.com/node/1679768?tsid=33#axzz64xWniAOP
-
Sukkeralf et al. ang BGB324, hvordan kan det være at der nogle pat. der ikke har en AXL score ? Har man ikke taget en biopsi før de indgik i forsøget ? De 12 uden AXL score er ligeligt fordelt ang. tumor effekt så måske ikke den store risiko bob-bob ?
-
Oncology Venture regner med at indsende NDA i andet halvår 2020. https://oncologyventure.com/press-release/oncology-venture-reaches-new-development-milestone-with-dovitinib/
-
Amarin er 20% oppe premarket på offentliggørelsen af Adcom dokument https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152220564 samt resultater fra et cost-effectiveness studie som naturligvis falder positivt ud til Vescepas fordel.https://finance.yahoo.com/news/analysis-shows-icosapent-ethyl-vascepa-181957479.html
-
MINERAL OIL DONE DEAL
FROM FDA BRIEFING DOCUMENT https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152220782
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind